Wynzora
Active substance: CALCIPOTRIENE, BETAMETHASONE DIPROPIONATE
CREAM · CALCIPOTRIENE 50 ug/g, BETAMETHASONE DIPROPIONATE 64 mg/g
United StatesActive
Marketing holder: MC2 Therapeutics Ltd
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- CALCIPOTRIENE · 50 ug/g
- BETAMETHASONE DIPROPIONATE · 64 mg/g
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-39af-783b-a06f-69a5a342ffb8,01a1208c-9c83-70ef-81a5-61d384d3eb84,01a1208d-8e83-72f8-830b-143fd5a8efff,01a1208e-6c66-77cb-908e-dd2230dc8458,01a1208e-6d19-7a4c-b893-71ec9d315ec2;count=11 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 73499-001
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- TOPICAL
Sources
- product · openFDA NDC · 73499-001 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 73499-001 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 73499-001 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 73499-001 · Verified 2026-10-09 · open in source